Carlo Donada

1.6k total citations
25 papers, 1.0k citations indexed

About

Carlo Donada is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, Carlo Donada has authored 25 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hepatology, 18 papers in Epidemiology and 6 papers in Rheumatology. Recurrent topics in Carlo Donada's work include Liver Disease Diagnosis and Treatment (18 papers), Hepatitis C virus research (16 papers) and Liver Disease and Transplantation (6 papers). Carlo Donada is often cited by papers focused on Liver Disease Diagnosis and Treatment (18 papers), Hepatitis C virus research (16 papers) and Liver Disease and Transplantation (6 papers). Carlo Donada collaborates with scholars based in Italy, Netherlands and Greece. Carlo Donada's co-authors include A. Albertí, Angelo Gatta, Liliana Chemello, Giorgio Cavallarin, Renato Marin, Pierluigi Torboli, Cesare Mazzaro, E. Bernardinello, Carlo Merkel and Valter Donadon and has published in prestigious journals such as The Lancet, Blood and Gastroenterology.

In The Last Decade

Carlo Donada

25 papers receiving 989 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carlo Donada Italy 18 911 769 287 210 49 25 1.0k
Satoshi Nakano Japan 17 450 0.5× 381 0.5× 303 1.1× 113 0.5× 21 0.4× 57 850
E. R. Dickson United States 9 667 0.7× 544 0.7× 303 1.1× 75 0.4× 74 1.5× 14 912
Harriet Mitchison United Kingdom 11 812 0.9× 731 1.0× 338 1.2× 122 0.6× 5 0.1× 17 1.0k
Anna Baiges Spain 18 669 0.7× 644 0.8× 300 1.0× 37 0.2× 51 1.0× 49 949
Giorgina Mieli-Vergani United Kingdom 11 368 0.4× 304 0.4× 154 0.5× 118 0.6× 7 0.1× 14 549
Masanori Atsukawa Japan 18 714 0.8× 729 0.9× 213 0.7× 74 0.4× 27 0.6× 85 1.0k
F.B. Bianchi Italy 10 276 0.3× 283 0.4× 132 0.5× 113 0.5× 10 0.2× 24 498
Odile Goria France 14 363 0.4× 236 0.3× 180 0.6× 65 0.3× 63 1.3× 39 613
Jurgen Ludwig United States 12 730 0.8× 507 0.7× 517 1.8× 45 0.2× 9 0.2× 12 945
Masaharu Ando Japan 15 403 0.4× 424 0.6× 216 0.8× 31 0.1× 39 0.8× 41 695

Countries citing papers authored by Carlo Donada

Since Specialization
Citations

This map shows the geographic impact of Carlo Donada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlo Donada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlo Donada more than expected).

Fields of papers citing papers by Carlo Donada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlo Donada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlo Donada. The network helps show where Carlo Donada may publish in the future.

Co-authorship network of co-authors of Carlo Donada

This figure shows the co-authorship network connecting the top 25 collaborators of Carlo Donada. A scholar is included among the top collaborators of Carlo Donada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlo Donada. Carlo Donada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mazzaro, Cesare, Francesca Zorat, Carlo Donada, et al.. (2005). Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study. Journal of Hepatology. 42(5). 632–638. 84 indexed citations
2.
Merkel, Carlo, Renato Marin, Paolo Angeli, et al.. (2004). A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis. Gastroenterology. 127(2). 476–484. 172 indexed citations
3.
Merkel, Carlo, Renato Marin, David Sacerdoti, et al.. (2000). Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Hepatology. 31(2). 324–329. 83 indexed citations
4.
Cavalletto, Luisa, Liliana Chemello, Carlo Donada, et al.. (2000). The pattern of response to interferon alpha (α-IFN) predicts sustained response to a 6-month α-IFN and ribavirin retreatment for chronic hepatitis C. Journal of Hepatology. 33(1). 128–134. 24 indexed citations
5.
Casiglia, Edoardo, Alberto Mazza, Valter Donadon, et al.. (2000). Cardiovascular mortality in non-insulin-dependent diabetes mellitus. A controlled study among 683 diabetics and 683 age- and sex-matched normal subjects. European Journal of Epidemiology. 16(7). 677–684. 30 indexed citations
6.
Bernardinello, E., Luisa Cavalletto, L. Chemello, et al.. (2000). Long-term clinical outcome after beta-interferon therapy in cirrhotic patients with chronic hepatitis C. TVVH Study Group.. PubMed. 46(30). 3216–22. 35 indexed citations
7.
Donada, Carlo, Antonio Crucitti, Valter Donadon, et al.. (1998). Systemic manifestations and liver disease in patients with chronic hepatitis C and type II or III mixed cryoglobulinaemia. Journal of Viral Hepatitis. 5(3). 179–185. 65 indexed citations
8.
Donada, Carlo, et al.. (1998). Interferon and Ribavirin Combination Therapy in Patients With Chronic Hepatitis C and Mixed Cryoglobulinemia. Blood. 92(8). 2983–2984. 2 indexed citations
9.
Donada, Carlo, Antonio Crucitti, Silvia Piva, et al.. (1998). Combination therapy with interferon plus ribavirin in patients with mixed cryoglobulinaemia associated to HCV chronic hepatitis unresponsive to ALFA interferon. Journal of Hepatology. 28. 193–193. 1 indexed citations
10.
Saracco, Giorgio Maria, E. Borghesio, Antonio Solinas, et al.. (1997). Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon α-2b for chronic hepatitis type C. Journal of Hepatology. 27(1). 56–62. 37 indexed citations
11.
Corona, Giuseppe, Giuseppe Toffoli, Martina Fabris, et al.. (1997). Homocysteine accumulation in human ovarian carcinoma ascitic/cystic fluids possibly caused by metabolic alteration of the methionine cycle in ovarian carcinoma cells. European Journal of Cancer. 33(8). 1284–1290. 24 indexed citations
12.
Chemello, Liliana, Luisa Cavalletto, Carlo Donada, et al.. (1997). Efficacy of a second cycle of interferon therapy in patients with chronic hepatitis C. Gastroenterology. 113(5). 1654–1659. 39 indexed citations
13.
Merkel, Carlo, Renato Marin, Elena Enzo, et al.. (1996). Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. The Lancet. 348(9043). 1677–1681. 104 indexed citations
14.
Merkel, Carlo, Massimo Bolognesi, Lorenza Caregaro, et al.. (1996). Optimizing the time-frame for the definition of bleeding-related death after acute variceal bleeding in cirrhosis. European Journal of Gastroenterology & Hepatology. 8(1). 75–80. 1 indexed citations
15.
Merkel, Carlo, Angelo Gatta, Carlo Donada, et al.. (1995). Long-term effect of nadolol or nadolol plus isosorbide-5-mononitrate on renal function and ascites formation in patients with cirrhosis. Hepatology. 22(3). 808–813. 29 indexed citations
16.
Chemello, Liliana, Luisa Cavalletto, Franco Noventa, et al.. (1995). Predictors of sustained response, relapse and no response in patients with chronic hepatitis C treated with interferon‐α. Journal of Viral Hepatitis. 2(2). 91–96. 53 indexed citations
17.
Albertí, A., Liliana Chemello, Paola Bonetti, et al.. (1993). Treatment with interferon(s) of community-acquired chronic hepatitis and cirrhosis type C. Journal of Hepatology. 17. S123–S126. 64 indexed citations
18.
Chemello, Liliana, D. Cavalletto, Patrizia Pontisso, et al.. (1993). Patterns of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis and their relationship to viral replication and liver disease. Hepatology. 17(2). 179–182. 47 indexed citations
19.
Inchiostro, S., G Bertoli, Giorgio Zanette, et al.. (1992). Increased urinary albumin excretion is associated with a cluster of metabolic alterations in type 2 diabetes mellitus. Acta Diabetologica. 29(3-4). 240–245. 2 indexed citations
20.
Angelis, Vasileios, et al.. (1988). Fibronectin decrease in liver cirrhosis is related to spleen size. Journal of Molecular Medicine. 66(12). 524–526. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Satoshi Nakano Breakdown of academic impact, for papers by E. R. Dickson Breakdown of academic impact, for papers by Harriet Mitchison Breakdown of academic impact, for papers by Anna Baiges Breakdown of academic impact, for papers by Giorgina Mieli-Vergani Breakdown of academic impact, for papers by Masanori Atsukawa Breakdown of academic impact, for papers by F.B. Bianchi Breakdown of academic impact, for papers by Odile Goria Breakdown of academic impact, for papers by Jurgen Ludwig Breakdown of academic impact, for papers by Masaharu Ando
Rankless by CCL
2026